LOGIN  |  REGISTER
Astria Therapeutics

Recent Insider Transactions - Taysha Gene Therapies (NASDAQ: TSHA)

Company
Name / Role
Date
Type
Price
# Shares
Value
Balance
NASDAQ TSHA Taysha Gene Therapies
Nagendran Sukumar / director, officer: President and Head of R&D
09/10/2025
Buy
$0.70
41,150
$29K
1.21M
NASDAQ TSHA Taysha Gene Therapies
Nagendran Sukumar / director, officer: President and Head of R&D
09/10/2025
Sell
$3.23
200,000
$646K
1.01M
NASDAQ TSHA Taysha Gene Therapies
Nagendran Sukumar / director, officer: President and Head of R&D
09/10/2025
Sell
$0.70
41,150
$29K
292,855
NASDAQ TSHA Taysha Gene Therapies
Nagendran Sukumar / director, officer: President and Head of R&D
08/21/2025
Sell
$2.85
57,054
$163K
1.17M
NASDAQ TSHA Taysha Gene Therapies
Alam Kamran / officer: CHIEF FINANCIAL OFFICER
08/21/2025
Sell
$2.85
54,491
$155K
1.19M